Abbotsford, Australia

Andrew Heaton

This inventor holds 19 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 7 EPO patents, primarily in Isoflavonoid Chemistry. Top assignees: Mei Pharma, Inc., Marshall Edwards, Inc., Novogen Research Pty Limited. Active years: 2007-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew Heaton. Retrieved from https://idiyas.com/inventor/andrew-heaton

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 19 

% Patents Active = 31.6


 

Average Co-Inventor Count = 2.4

ph-index = 10

Forward Citations = 205(Granted Patents)


Location History:

  • New South Wales, AU (2010)
  • Forest Lodge, AU (2013)
  • Abbotsford, AU (2007 - 2015)
  • Alexandria, AU (2014 - 2023)

Company Filing History:


Years Active: 2007-2023

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Isoflavonoid Compounds
Chroman Derivatives
Medicaments
Cancer Treatment
Therapeutic Methods
Isoflavone Derivatives
Dimeric Isoflavones
Aminated Derivatives
Substituted Chromans
Oxazinyl Compounds
Therapeutic Applications
19 patents (USPTO):Explore Patents

Title: Andrew Heaton: Innovator in Cancer Treatment

Introduction:

Andrew Heaton, a prolific inventor based in Abbotsford, Australia, holds an impressive portfolio of 19 patents. His work primarily focuses on the development of innovative pharmaceutical compositions and methods aimed at addressing significant health challenges, particularly in cancer treatment.

Latest Patents:

Among his latest contributions to the scientific community are patents concerning isoflavonoid compounds. These patents detail pharmaceutical compositions that comprise at least one isoflavonoid. The methods outlined within these patents describe approaches for treating cancer, sensitizing cancer cells, and inducing apoptosis in cancer cells through the administration of these inventive compositions.

Career Highlights:

Throughout his career, Andrew Heaton has made significant strides in the pharmaceutical industry. He has worked with notable companies including Mei Pharma, Inc. and Novogen Research Pty Limited. His experiences and research within these esteemed organizations have greatly contributed to his development as an inventor and innovator.

Collaborations:

Andrew has collaborated with talented individuals in his field, including Alan James Husband and Naresh Kumar. These partnerships have fostered a collaborative environment that stimulates innovative ideas and enhances the quality of research and development in cancer treatment.

Conclusion:

With a strong focus on isoflavonoid compounds and their therapeutic potential in cancer treatment, Andrew Heaton continues to make valuable contributions to the field of pharmaceutical sciences. His inventive work not only underscores his capabilities as an inventor but also highlights the importance of collaboration and innovation in advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…